| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Fabián Jaimes | |
| César Caraballo | |||
| P2860 | cites work | Comparison of Dopamine and Norepinephrine in the Treatment of Shock | Q22250880 |
| Fluid Resuscitation in Sepsis | Q22305304 | ||
| Epidemiology of severe sepsis | Q22305425 | ||
| Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality | Q24621520 | ||
| The microcirculation is the motor of sepsis | Q24633735 | ||
| Comparison of the accuracy of three early warning scores with SOFA score for predicting mortality in adult sepsis and septic shock patients admitted to intensive care unit | Q92560554 | ||
| Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems | Q93341013 | ||
| Bench-to-bedside review: Cytopathic hypoxia | Q24807180 | ||
| The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) | Q26768286 | ||
| Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) | Q26768292 | ||
| The coagulopathy of acute sepsis | Q26826950 | ||
| The role of the liver in sepsis | Q26864861 | ||
| Severe sepsis and septic shock | Q27026614 | ||
| Hypoxic Hepatitis: A Review and Clinical Update | Q28078274 | ||
| The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death | Q28282816 | ||
| Acute respiratory distress syndrome: the Berlin Definition | Q29615138 | ||
| Incidence and outcomes of acute lung injury | Q29615139 | ||
| 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference | Q29618757 | ||
| The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine | Q29618869 | ||
| Acute kidney injury in sepsis. | Q30235009 | ||
| Early, Goal-Directed Therapy for Septic Shock - A Patient-Level Meta-Analysis | Q30572421 | ||
| The encephalopathy in sepsis | Q31145115 | ||
| The hematologic system as a marker of organ dysfunction in sepsis | Q33348784 | ||
| Thrombocytopenia in septic shock patients--a prospective observational study of incidence, risk factors and correlation with clinical outcome | Q33377823 | ||
| Epidemiology and prognostic factors in severe sepsis/septic shock. Evolution over six years | Q33420945 | ||
| Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome | Q33421465 | ||
| Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). | Q33692899 | ||
| Pattern of brain injury in the acute setting of human septic shock | Q33753392 | ||
| Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. | Q34130693 | ||
| Simplified severe sepsis protocol: a randomized controlled trial of modified early goal-directed therapy in Zambia | Q34353258 | ||
| Long-term outcomes following development of new-onset atrial fibrillation during sepsis | Q34448321 | ||
| Cognitive decline after sepsis | Q34450127 | ||
| Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS | Q34553590 | ||
| Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation | Q34744890 | ||
| Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock | Q35621102 | ||
| Prognostic significance of the angiopoietin-2/angiopoietin-1 and angiopoietin-1/Tie-2 ratios for early sepsis in an emergency department | Q36159586 | ||
| Balanced Crystalloids versus Saline in the Intensive Care Unit. The SALT Randomized Trial | Q39282707 | ||
| Occult hypoperfusion and mortality in patients with suspected infection | Q39804211 | ||
| Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014. | Q40048733 | ||
| Prognostic impact of isolated right ventricular dysfunction in sepsis and septic shock: an 8-year historical cohort study | Q40051663 | ||
| Recognizing Sepsis as a Global Health Priority - A WHO Resolution | Q40154811 | ||
| Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations | Q40491993 | ||
| Quick Sepsis-related Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and Early Warning Scores for Detecting Clinical Deterioration in Infected Patients outside the Intensive Care Unit | Q40533921 | ||
| Understanding circulatory failure in sepsis. | Q40543074 | ||
| Site of infection and mortality in patients with severe sepsis or septic shock. A cohort study of patients admitted to a Danish general intensive care unit | Q40621516 | ||
| Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes | Q40667140 | ||
| Longitudinal Study of the Effects of Bacteremia and Sepsis on 5-year Risk of Cardiovascular Events. | Q40668939 | ||
| Infection site is predictive of outcome in acute lung injury associated with severe sepsis and septic shock | Q40735734 | ||
| Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study | Q41719170 | ||
| Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical Trial. | Q41925460 | ||
| Sepsis-Induced Cardiomyopathy: Mechanisms and Treatments | Q42362538 | ||
| Systemic infection and delirium: when cytokines and acetylcholine collide | Q43147571 | ||
| Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration | Q43238982 | ||
| Proinflammatory cytokines inhibit secretion in rat bile duct epithelium. | Q43662711 | ||
| A prospective analysis of disseminated intravascular coagulation in patients with infections | Q44033357 | ||
| Association between mitochondrial dysfunction and severity and outcome of septic shock | Q44074137 | ||
| Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis | Q44460646 | ||
| Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock | Q46072670 | ||
| Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program | Q46444641 | ||
| Myocardial Injury in Patients With Sepsis and Its Association With Long-Term Outcome | Q47555255 | ||
| Epidemiology, causes, evolution and outcome in a single-center cohort of 1116 critically ill patients with hypoxic hepatitis. | Q47643144 | ||
| Angiopoietins: a link between angiogenesis and inflammation. | Q36625591 | ||
| Vasopressin: mechanisms of action on the vasculature in health and in septic shock | Q36667777 | ||
| Mechanisms of sepsis-induced cardiac dysfunction | Q36799073 | ||
| New paradigms in sepsis: from prevention to protection of failing microcirculation | Q37238202 | ||
| Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review | Q37353227 | ||
| Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside | Q37791460 | ||
| Sepsis-associated encephalopathy | Q38044198 | ||
| Clinical review: The liver in sepsis | Q38058384 | ||
| Thrombomodulin in sepsis | Q38067550 | ||
| Vasoplegia in septic shock: do we really fight the right enemy? | Q38149625 | ||
| Correlation of left ventricular systolic dysfunction determined by low ejection fraction and 30-day mortality in patients with severe sepsis and septic shock: a systematic review and meta-analysis | Q38205576 | ||
| New directions for sepsis and septic shock research | Q38321867 | ||
| Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial | Q38386593 | ||
| Diastolic dysfunction and mortality in septic patients: a systematic review and meta-analysis. | Q38387924 | ||
| Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries | Q38395601 | ||
| Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. | Q38433744 | ||
| The Economic and Humanistic Burden of Severe Sepsis | Q38455028 | ||
| Cholestatic liver (dys)function during sepsis and other critical illnesses | Q38590747 | ||
| Cardiovascular dysfunction in sepsis at the dawn of emerging mediators | Q38608262 | ||
| A rational approach to fluid therapy in sepsis | Q38617704 | ||
| Heart rate variability as predictor of mortality in sepsis: A prospective cohort study | Q38706837 | ||
| Neurology of Sepsis | Q38714969 | ||
| Risk of Acute Coronary Heart Disease After Sepsis Hospitalization in the REasons for Geographic and Racial Differences in Stroke Cohort | Q38736141 | ||
| SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis | Q38753960 | ||
| Cardiac hyporesponsiveness in severe sepsis is associated with nitric oxide-dependent activation of G protein receptor kinase. | Q38773781 | ||
| Microcirculatory dysfunction in sepsis: pathophysiology, clinical monitoring, and potential therapies | Q38815302 | ||
| Mortality after fluid bolus in African children with severe infection | Q38870112 | ||
| Mechanical Ventilation in Sepsis: A Reappraisal. | Q38907563 | ||
| Risk of Acute Stroke After Hospitalization for Sepsis: A Case-Crossover Study | Q38961607 | ||
| Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis | Q38979212 | ||
| Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit | Q39004033 | ||
| Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice. | Q39028464 | ||
| Liver - guardian, modifier and target of sepsis | Q39031051 | ||
| Hemodynamic coherence in sepsis. | Q39033282 | ||
| Impact of thrombosis on pulmonary endothelial injury and repair following sepsis | Q39107051 | ||
| Acute kidney injury in patients with severe sepsis in Finnish Intensive Care Units | Q48004171 | ||
| The neuropathology of septic shock. | Q48007037 | ||
| Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock | Q48126570 | ||
| Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms | Q48247612 | ||
| Severe sepsis and cardiac arrhythmias | Q48505769 | ||
| Association of Clinical Hypoperfusion Variables with Lactate Clearance and Hospital Mortality | Q50067503 | ||
| Sepsis in Older Adults | Q50099650 | ||
| Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. | Q51670034 | ||
| Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. | Q51683065 | ||
| Balanced Crystalloids versus Saline in Noncritically Ill Adults. | Q52683172 | ||
| Balanced Crystalloids versus Saline in Critically Ill Adults. | Q52683174 | ||
| qSOFA, SIRS and NEWS for predicting inhospital mortality and ICU admission in emergency admissions treated as sepsis. | Q52691672 | ||
| Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment. | Q52691987 | ||
| Improving the Accuracy of Cardiovascular Component of the Sequential Organ Failure Assessment Score. | Q53288934 | ||
| Sepsis in European intensive care units: results of the SOAP study. | Q54471944 | ||
| Predictors of response to fixed-dose vasopressin in adult patients with septic shock. | Q54956950 | ||
| Drotrecogin alfa (activated) in adults with septic shock. | Q55056165 | ||
| Progression into sepsis: an individualized process varying by the interaction of comorbidities with the underlying infection. | Q55432715 | ||
| The global burden of sepsis: barriers and potential solutions | Q56909229 | ||
| The role of biomarkers of endothelial activation in predicting morbidity and mortality in patients with severe sepsis and septic shock in intensive care: A prospective observational study | Q57489142 | ||
| Heart rate variability as predictor of mortality in sepsis: A systematic review | Q58752263 | ||
| Acute Renal Failure in Critically Ill Patients A Multinational, Multicenter Study | Q61363260 | ||
| Septic Acute Kidney Injury in Critically Ill Patients: Clinical Characteristics and Outcomes | Q61661940 | ||
| Timing of administration of epinephrine predicts the responsiveness to epinephrine in norepinephrine-refractory septic shock: a retrospective study | Q64072823 | ||
| Prognostic accuracy of the serum lactate level, the SOFA score and the qSOFA score for mortality among adults with Sepsis | Q64080339 | ||
| Neutrophils disturb pulmonary microcirculation in sepsis-induced acute lung injury | Q64106613 | ||
| Broad spectrum vasopressors: a new approach to the initial management of septic shock? | Q64107671 | ||
| Cardiovascular determinants of resuscitation from sepsis and septic shock | Q64112965 | ||
| Current use of vasopressors in septic shock | Q64126327 | ||
| Association between site of infection and in-hospital mortality in patients with sepsis admitted to emergency departments of tertiary hospitals in Medellin, Colombia | Q64289260 | ||
| American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis | Q68141412 | ||
| Validation of a modified Early Warning Score in medical admissions | Q74596079 | ||
| EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units | Q76401271 | ||
| Septic shock: a heart story since the 1960s | Q82997240 | ||
| Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock | Q83177700 | ||
| Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study) | Q83395033 | ||
| The acute respiratory distress syndrome | Q84693193 | ||
| KDIGO clinical practice guidelines for acute kidney injury | Q84789239 | ||
| Thrombocytopenia: A Risk Factor of Mortality for Patients with Sepsis in the Intensive Care Unit | Q87695938 | ||
| Sepsis-induced acute kidney injury: A disease of the microcirculation | Q89122454 | ||
| Fluid Management in Sepsis | Q89478278 | ||
| Sepsis associated acute kidney injury | Q90969155 | ||
| Development and Evaluation of a Machine Learning Model for the Early Identification of Patients at Risk for Sepsis | Q91129680 | ||
| Antibiotics has more impact on mortality than other early goal-directed therapy components in patients with sepsis: An instrumental variable analysis | Q91463328 | ||
| Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial | Q91652838 | ||
| Cardiovascular Events and Hospital Deaths Among Patients With Severe Sepsis | Q91655230 | ||
| How we manage haemostasis during sepsis | Q92091384 | ||
| Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial | Q92138282 | ||
| Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis | Q92138291 | ||
| Risk Factors for Stroke in Patients With Sepsis and Bloodstream Infections | Q92522151 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P433 | issue | 4 | |
| P921 | main subject | sepsis | Q183134 |
| multiple organ dysfunction syndrome | Q1193870 | ||
| P304 | page(s) | 629-640 | |
| P577 | publication date | 2019-12-01 | |
| 2019-12-20 | |||
| P1433 | published in | Yale Journal of Biology and Medicine | Q15709982 |
| P1476 | title | Organ Dysfunction in Sepsis: An Ominous Trajectory From Infection To Death | |
| P478 | volume | 92 |
Search more.